Abstract:Highlights • Magnetic targeting spinel ferrite for enhancing microwave thermal therapy. • Nanoparticles loaded with zoledronic acid can target bone metastasis. • Synergistic cancer therapy via chemodynamic and microwave dynamic. • Depletion of glutathione, zoledronic acid and reactive oxygen species. • Zoledronic acid and Mg activate osteogenesis and antitumor. Once bone metastasis occurs in lung cancer, the efficiency of treatment can be greatly reduced. Current mainstream treatments are focused on inhibiting cancer cell growth and preventing bone destruction. Microwave ablation (MWA) has been used to treat bone tumors. However, MWA may damage the surrounding normal tissues. Therefore, it could be beneficial to develop a nanocarrier combined with microwave to treat bone metastasis. Herein, a microwave-responsive nanoplatform (MgFe 2 O 4 @ZOL) was constructed. MgFe 2 O 4 @ZOL NPs release the cargos of Fe 3+ , Mg 2+ and zoledronic acid (ZOL) in the acidic tumor microenvironment (TME). Fe 3+ can deplete intracellular glutathione (GSH) and catalyze H 2 O 2 to generate •OH, resulting in chemodynamic therapy (CDT). In addition, the microwave can significantly enhance the production of reactive oxygen species (ROS), thereby enabling the effective implementation of microwave dynamic therapy (MDT). Moreover, Mg 2+ and ZOL promote osteoblast differentiation. In addition, MgFe 2 O 4 @ZOL NPs could target and selectively heat tumor tissue and enhance the effect of microwave thermal therapy (MTT). Both in vitro and in vivo experiments revealed that synergistic targeting, GSH depletion-enhanced CDT, MDT, and selective MTT exhibited significant antitumor efficacy and bone repair. This multimodal combination therapy provides a promising strategy for the treatment of bone metastasis in lung cancer patients. Graphical abstract Download : Download high-res image (391KB) Download : Download full-size image

Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption.

Redox and Ph Dual Sensitive Bone Targeting Nanoparticles to Treat Breast Cancer Bone Metastases and Inhibit Bone Resorption.

Bone-targeted PAMAM micelle to treat bone metastases of lung cancer

Doxorubicin-Poly (ethylene Glycol)-Alendronate Self-Assembled Micelles for Targeted Therapy of Bone Metastatic Cancer

Osteoclasts and Tumor Cells Dual Targeting Nanoparticle to Treat Bone Metastases of Lung Cancer

DOX-loaded Mesoporous Hydroxyapatite Modified by Hyaluronic Acid Can Achieve Efficient Targeted Therapy for Lung Cancer.

Bone-Targeted Mesoporous Silica Nanocarrier Anchored by Zoledronate for Cancer Bone Metastasis

Actively Targeted Delivery of Doxorubicin to Bone Metastases by a Ph-Sensitive Conjugation

Bone-targeted nanoplatform enables efficient modulation of bone tumor microenvironment for prostate cancer bone metastasis treatment

Docetaxel-loaded Bovine Serum Albumin Nanoparticles Conjugated Docosahexaenoic Acid for Inhibiting Lung Cancer Metastasis to Bone.

Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer

Inhibition of Metastatic Bone Cancer with a Cascade Targeting of Docetaxel

Bortezomib-catechol Conjugated Prodrug Micelles: Combining Bone Targeting and Aryl Boronate-Based Ph-Responsive Drug Release for Cancer Bone-Metastasis Therapy

Dual-active targeting liposomes drug delivery system for bone metastatic breast cancer: Synthesis and biological evaluation

Bone-targeted Oxidative Stress Nanoamplifier for Synergetic Chemo/chemodynamic Therapy of Bone Metastases Through Increasing Generation and Reducing Elimination of ROS

Bone-Targeted Nanoplatform Combining Zoledronate and Photothermal Therapy To Treat Breast Cancer Bone Metastasis

Metal-Organic Framework Nanoparticles for Ameliorating Breast Cancer Associated Osteolysis.

Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors

Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant

Targeting nanoplatform synergistic glutathione depletion-enhanced chemodynamic, microwave dynamic, and selective-microwave thermal to treat lung cancer bone metastasis

Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer